Novus Biologicals, LLC
PO Box 802; Littleton, CO, 80160 USA
Phone: 303.730.1950 Fax: 303.730.1966


ADAM23 Antibody (NB100-75282)

ADAM23 Antibody

Catalog#: NB100-75282 100% Guarantee
This product is fully covered under guarantee+
Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Buffer: Phosphate-Buffered Saline pH7.2
Preservative: 0.02% Sodium Azide
Purity: Immunogen affinity purified
Host: Ch
Clonality: Polyclonal
Specificity: ADAM 23
Modification: No
Isotype: IgY
Immunogen: The immunogen for this antibody was a sequence from 72a.a. to 144a.a. from ADAM 23(a 832a.a. long protein)
Entrez: 8745 (Human)
Related Genes: 8745
Swiss Prot: O75077 (Human)
Background:
ADAM23 is a non-catalytic metalloprotease-like protein. It is highly expressed in the brain, primarily in the amygdala, caudate nucleus, hypothalamus, thalamus, cerebral cortex and occipital pole, and weakly expressed in the heart. 3 isoforms are produced by alternative splicing, alpha, beta and gamma. ADAM23 may play a role in cell-cell and cell-matrix interactions. May play a role in cell-cell and cell-matrix interactions. This is a non-catalytic metalloprotease-like protein.
Hu
reactivity: This antibody is reactive against Human..
WB
Uses: Western Blot: E coli-derived fusion protein as test antigen. Affinity-purified IgY dilution: 1:2000. Goat anti-IgY-HRP dilution: 1:1000. Colorimetric method for signal development.
Dilutions: Western Blot
Publications: [1] Takada,H., Imoto,I., Tsuda,H., Nakanishi,Y., Ichikura,T., Mochizuki,H., Mitsufuji,S., Hosoda,F., Hirohashi,S., Ohki,M. , et al. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation [2] Costa,F.F., Colin,C., Shinjo,S.M., Zanata,S.M., Marie,S.K., Sogayar,M.C. Camargo,A.A. ADAM23 methylation expression analysis in brain tumors [3] Brenberger,R., Wei,H., Zhang,S., Lei,S., Murage,J., Fisk,G.J., Li,Y., Xu,C., Fang,R., Guegler,K., Rao,M.S., Malam,R.,, et al. Transcriptome characterization elucidates signaling networks that control human ES cell growth differentiation
Reviews
No reviews have been submitted for this product.

Working with ADAM23

Publications (8)
General:

[1] Takada,H., Imoto,I., Tsuda,H., Nakanishi,Y., Ichikura,T., Mochizuki,H., Mitsufuji,S., Hosoda,F., Hirohashi,S., Ohki,M. , et al. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation

[2] Costa,F.F., Colin,C., Shinjo,S.M., Zanata,S.M., Marie,S.K., Sogayar,M.C. Camargo,A.A. ADAM23 methylation expression analysis in brain tumors

[3] Brenberger,R., Wei,H., Zhang,S., Lei,S., Murage,J., Fisk,G.J., Li,Y., Xu,C., Fang,R., Guegler,K., Rao,M.S., Malam,R.,, et al. Transcriptome characterization elucidates signaling networks that control human ES cell growth differentiation

8 general publications available on website.


 
Images (1)
Western Blot: E coli-derived fusion protein as test antigen. Affinity-purified IgY dilution: 1:2000, Goat anti-IgY-HRP dilution: 1:1000. Colorimetric method for signal development. ( anti-ADAM23 ) Western Blot: E coli-derived fusion protein as test antigen. Affinity-purified IgY dilution: 1:2000, Goat anti-IgY-HRP dilution: 1:1000. Colorimetric method for signal development. ( anti-ADAM23 )